The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNorthern Jiangsu People's Hospital

About this trial

In this study, the investigators compared the improvement of immune function related indicators in patients with liver cirrhosis after laparoscopic splenectomy and azygoportal disconnection. To determine whether surgical treatment can help enhance postoperative immune function and improve patient prognosis.

Eligibility criteria

Qualifiers

A clinical, radiological or histologic diagnosis of cirrhosis of any etiology

Splenomegaly with secondary hypersplenism

gastroesophageal variceal bleeding

Informed consent to participate in the study

Disqualifiers

Hepatocellular carcinoma or any other malignancy,

Child-Pugh grade C

Recent peptic ulcer disease

History of Hemorrhagic stroke

Trial design

Treatments tested in this trial

  • Laparoscopic splenectomy and azygoportal disconnection

Treatment groups

20 Participants
are divided into 1 treatment group